neostigmine has been researched along with Cardiac Hypertrophy in 3 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we tested the effects of a cholinesterase inhibitor, neostigmine, and a muscarinic cholinergic agonist, pilocarpine, on cardiac hypertrophy and TNF alpha levels during pressure overload." | 7.74 | Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. ( Freeling, J; LaCroix, C; Li, YF; Wattier, K, 2008) |
| " In the present study, we tested the effects of a cholinesterase inhibitor, neostigmine, and a muscarinic cholinergic agonist, pilocarpine, on cardiac hypertrophy and TNF alpha levels during pressure overload." | 3.74 | Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. ( Freeling, J; LaCroix, C; Li, YF; Wattier, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BAUER, GE | 1 |
| Freeling, J | 1 |
| Wattier, K | 1 |
| LaCroix, C | 1 |
| Li, YF | 1 |
| James, TN | 1 |
3 other studies available for neostigmine and Cardiac Hypertrophy
| Article | Year |
|---|---|
BUNDLE-BRANCH BLOCK UNDER VOLUNTARY CONTROL.
Topics: Atropine; Bundle-Branch Block; Cardiac Conduction System Disease; Cardiomegaly; Carotid Sinus; Diagn | 1964 |
Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload.
Topics: Animals; Animals, Newborn; Body Weight; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Dru | 2008 |
Small arteries of the heart.
Topics: Acetylcholine; Amyloidosis; Animals; Arterial Occlusive Diseases; Arteries; Cardiomegaly; Coronary V | 1977 |